Hepatitis B Vaccine (Recombinant) Completed Phase 4 Trials for Viral Hepatitis B Basic Science

IndicationsStatusPurposePhase
CompletedBasic Science4
clinicaltrials.gov IdentifierTitleDrugs
NCT01821547New Methods to Measure the Immune Response to Hepatitis B Vaccine